These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 25859844)

  • 1. Overexpression of Roundabout4 predicts poor prognosis of primary glioma patients via correlating with microvessel density.
    Cai H; Xue Y; Liu W; Li Z; Hu Y; Li Z; Shang X; Liu Y
    J Neurooncol; 2015 May; 123(1):161-9. PubMed ID: 25859844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An integrated transcriptomic and computational analysis for biomarker identification in human glioma.
    Xing W; Zeng C
    Tumour Biol; 2016 Jun; 37(6):7185-92. PubMed ID: 26663173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiRNA expression profiling in human gliomas: upregulated miR-363 increases cell survival and proliferation.
    Conti A; Romeo SG; Cama A; La Torre D; Barresi V; Pezzino G; Tomasello C; Cardali S; Angileri FF; Polito F; Ferlazzo G; Di Giorgio R; Germanò A; Aguennouz M
    Tumour Biol; 2016 Oct; 37(10):14035-14048. PubMed ID: 27495233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced expression of microRNA-497 is associated with greater angiogenesis and poor prognosis in human gliomas.
    Feng F; Kuai D; Wang H; Li T; Miao W; Liu Y; Fan Y
    Hum Pathol; 2016 Dec; 58():47-53. PubMed ID: 27569294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of p-Smad2 contributes to FAT10-induced oncogenic activities in glioma.
    Dai B; Zhang Y; Zhang P; Pan C; Xu C; Wan W; Wu Z; Zhang J; Zhang L
    Tumour Biol; 2016 Jul; 37(7):8621-31. PubMed ID: 26733179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of expression and prognostic significance of vimentin and the response to temozolomide in glioma patients.
    Lin L; Wang G; Ming J; Meng X; Han B; Sun B; Cai J; Jiang C
    Tumour Biol; 2016 Nov; 37(11):15333-15339. PubMed ID: 27704357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DDX3X Biomarker Correlates with Poor Survival in Human Gliomas.
    Hueng DY; Tsai WC; Chiou HY; Feng SW; Lin C; Li YF; Huang LC; Lin MH
    Int J Mol Sci; 2015 Jul; 16(7):15578-91. PubMed ID: 26184164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Slit2 and Robo1 expression as biomarkers for assessing prognosis in brain glioma patients.
    Liu L; Li W; Geng S; Fang Y; Sun Z; Hu H; Liang Z; Yan Z
    Surg Oncol; 2016 Dec; 25(4):405-410. PubMed ID: 27916173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelin B receptor expression in malignant gliomas: the perivascular immune escape mechanism of gliomas.
    Nakashima S; Sugita Y; Miyoshi H; Arakawa F; Muta H; Ishibashi Y; Niino D; Ohshima K; Terasaki M; Nakamura Y; Morioka M
    J Neurooncol; 2016 Mar; 127(1):23-32. PubMed ID: 26645886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of Delta-like ligand 4 (DLL4) with VEGF and HIF-1α expression in human glioma.
    Li Z; Wang J; Gong L; Wen Z; Xu C; Huang X
    Asian Pac J Cancer Prev; 2011; 12(1):215-8. PubMed ID: 21517260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-584-3p, a novel tumor suppressor and prognostic marker, reduces the migration and invasion of human glioma cells by targeting hypoxia-induced ROCK1.
    Xue H; Guo X; Han X; Yan S; Zhang J; Xu S; Li T; Guo X; Zhang P; Gao X; Liu Q; Li G
    Oncotarget; 2016 Jan; 7(4):4785-805. PubMed ID: 26715733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of phosphatidylethanolamine-binding protein 4 (PEBP4) strongly associates with human gliomas grade.
    Huang RQ; Shi DL; Huang W; Chen F; Lu YC
    J Neurooncol; 2016 Apr; 127(2):235-42. PubMed ID: 26725095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deregulated expression of cry1 and cry2 in human gliomas.
    Luo Y; Wang F; Chen LA; Chen XW; Chen ZJ; Liu PF; li FF; Li CY; Liang W
    Asian Pac J Cancer Prev; 2012; 13(11):5725-8. PubMed ID: 23317246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ProBDNF and its receptors are upregulated in glioma and inhibit the growth of glioma cells in vitro.
    Xiong J; Zhou L; Yang M; Lim Y; Zhu YH; Fu DL; Li ZW; Zhong JH; Xiao ZC; Zhou XF
    Neuro Oncol; 2013 Aug; 15(8):990-1007. PubMed ID: 23576602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High CHI3L1 expression is associated with glioma patient survival.
    Steponaitis G; Skiriutė D; Kazlauskas A; Golubickaitė I; Stakaitis R; Tamašauskas A; Vaitkienė P
    Diagn Pathol; 2016 Apr; 11():42. PubMed ID: 27121858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-320a functions as a suppressor for gliomas by targeting SND1 and β-catenin, and predicts the prognosis of patients.
    Li H; Yu L; Liu J; Bian X; Shi C; Sun C; Zhou X; Wen Y; Hua D; Zhao S; Ren L; An T; Luo W; Wang Q; Yu S
    Oncotarget; 2017 Mar; 8(12):19723-19737. PubMed ID: 28160566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of p42.3 in low- and high-grade gliomas.
    Wan W; Xu X; Jia G; Li W; Wang J; Ren T; Wu Z; Zhang J; Zhang L; Lu Y
    World J Surg Oncol; 2014 Jun; 12():185. PubMed ID: 24927751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of SRPK1 in gliomas and its role in glioma cell lines viability.
    Sigala I; Tsamis KI; Gousia A; Alexiou G; Voulgaris S; Giannakouros T; Kyritsis AP; Nikolakaki E
    Tumour Biol; 2016 Jul; 37(7):8699-707. PubMed ID: 26738865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roundabout4 suppresses glioma-induced endothelial cell proliferation, migration and tube formation in vitro by inhibiting VEGR2-mediated PI3K/AKT and FAK signaling pathways.
    Cai H; Xue Y; Li Z; Hu Y; Wang Z; Liu W; Li Z; Liu Y
    Cell Physiol Biochem; 2015; 35(5):1689-705. PubMed ID: 25833462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of the Regulation of Roundabout4 by Hypoxia-Inducible Factor-1α in Microvascular Endothelial Cells.
    Tian R; Liu Z; Zhang H; Fang X; Wang C; Qi S; Cheng Y; Su G
    Invest Ophthalmol Vis Sci; 2015 Apr; 56(4):2586-94. PubMed ID: 26066603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.